Endoplasmic reticulum stress and NF‐kB activation in SARS‐CoV‐2 infected cells and their response to antiviral therapy. Issue 1 (13th August 2021)
- Record Type:
- Journal Article
- Title:
- Endoplasmic reticulum stress and NF‐kB activation in SARS‐CoV‐2 infected cells and their response to antiviral therapy. Issue 1 (13th August 2021)
- Main Title:
- Endoplasmic reticulum stress and NF‐kB activation in SARS‐CoV‐2 infected cells and their response to antiviral therapy
- Authors:
- Bartolini, Desirée
Stabile, Anna Maria
Vacca, Carmine
Pistilli, Alessandra
Rende, Mario
Gioiello, Antimo
Cruciani, Gabriele
Galli, Francesco - Other Names:
- Ozer Nesrin Kartal guestEditor.
Vina Jose guestEditor.
Olaso Gloria guestEditor.
Sozen Erdi guestEditor. - Abstract:
- Abstract: Unfolded protein response (UPR) and endoplasmic reticulum (ER) stress are aspects of SARS‐CoV‐2‐host cell interaction with proposed role in the cytopathic and inflammatory pathogenesis of this viral infection. The role of the NF‐kB pathway in these cellular processes remains poorly characterized. When investigated in VERO‐E6 cells, SARS‐CoV‐2 infection was found to markedly stimulate NF‐kB protein expression and activity. NF‐kB activation occurs early in the infection process (6 hpi) and it is associated with increased MAPK signaling and expression of the UPR inducer IRE‐1α. These signal transduction processes characterize the cellular stress response to the virus promoting a pro‐inflammatory environment and caspase activation in the host cell. Inhibition of viral replication by the viral protease inhibitor Nelfinavir reverts all these molecular changes also stimulating c ‐Jun expression, a key component of the JNK/AP‐1 pathway with important role in the IRE‐1α‐mediated transcriptional regulation of stress response genes with anti‐inflammatory and cytoprotection function. The present study demonstrates that UPR signaling and its interaction with cellular MAPKs and the NF‐kB activity are important aspects of SARS‐CoV‐2‐host cell interaction that deserve further investigation to identify more efficient therapies for this viral infection.
- Is Part Of:
- IUBMB life. Volume 74:Issue 1(2022)
- Journal:
- IUBMB life
- Issue:
- Volume 74:Issue 1(2022)
- Issue Display:
- Volume 74, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 74
- Issue:
- 1
- Issue Sort Value:
- 2022-0074-0001-0000
- Page Start:
- 93
- Page End:
- 100
- Publication Date:
- 2021-08-13
- Subjects:
- c‐Jun -- COVID‐19 -- inflammation -- Nelfinavir -- NF‐kB -- Remdesivir -- SARS‐CoV‐2 -- stress response -- VERO‐E6 cells
Biochemistry -- Periodicals
Molecular biology -- Periodicals
572.8 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-6551 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/iub.2537 ↗
- Languages:
- English
- ISSNs:
- 1521-6543
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4588.826000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26741.xml